BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17887661)

  • 1. Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators.
    Martinborough E; Shen Y; Oeveren Av; Long YO; Lau TL; Marschke KB; Chang WY; López FJ; Vajda EG; Rix PJ; Viveros OH; Negro-Vilar A; Zhi L
    J Med Chem; 2007 Oct; 50(21):5049-52. PubMed ID: 17887661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective androgen receptor modulators based on a series of 7H-[1,4]oxazino[3,2-g]quinolin-7-ones with improved in vivo activity.
    Long YO; Higuchi RI; Caferro TR; Lau TL; Wu M; Cummings ML; Martinborough EA; Marschke KB; Chang WY; López FJ; Karanewsky DS; Zhi L
    Bioorg Med Chem Lett; 2008 May; 18(9):2967-71. PubMed ID: 18400499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones.
    Higuchi RI; Arienti KL; López FJ; Mani NS; Mais DE; Caferro TR; Long YO; Jones TK; Edwards JP; Zhi L; Schrader WT; Negro-Vilar A; Marschke KB
    J Med Chem; 2007 May; 50(10):2486-96. PubMed ID: 17439112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of potent and muscle selective androgen receptor modulators through scaffold modifications.
    Li JJ; Sutton JC; Nirschl A; Zou Y; Wang H; Sun C; Pi Z; Johnson R; Krystek SR; Seethala R; Golla R; Sleph PG; Beehler BC; Grover GJ; Fura A; Vyas VP; Li CY; Gougoutas JZ; Galella MA; Zahler R; Ostrowski J; Hamann LG
    J Med Chem; 2007 Jun; 50(13):3015-25. PubMed ID: 17552509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 6-N,N-bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a novel selective androgen receptor modulator.
    van Oeveren A; Motamedi M; Mani NS; Marschke KB; López FJ; Schrader WT; Negro-Vilar A; Zhi L
    J Med Chem; 2006 Oct; 49(21):6143-6. PubMed ID: 17034117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators.
    Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    J Med Chem; 2007 Aug; 50(16):3857-69. PubMed ID: 17636947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones.
    van Oeveren A; Motamedi M; Martinborough E; Zhao S; Shen Y; West S; Chang W; Kallel A; Marschke KB; López FJ; Negro-Vilar A; Zhi L
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1527-31. PubMed ID: 17267219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I.
    Aikawa K; Miyawaki T; Hitaka T; Imai YN; Hara T; Miyazaki J; Yamaoka M; Kusaka M; Kanzaki N; Tasaka A; Shiraishi M; Yamamoto S
    Bioorg Med Chem; 2015 May; 23(10):2568-78. PubMed ID: 25862209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a 4-(hydroxymethyl)diarylhydantoin as a selective androgen receptor modulator.
    Nique F; Hebbe S; Triballeau N; Peixoto C; Lefrançois JM; Jary H; Alvey L; Manioc M; Housseman C; Klaassen H; Van Beeck K; Guédin D; Namour F; Minet D; Van der Aar E; Feyen J; Fletcher S; Blanqué R; Robin-Jagerschmidt C; Deprez P
    J Med Chem; 2012 Oct; 55(19):8236-47. PubMed ID: 22957947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of diarylhydantoins as new selective androgen receptor modulators.
    Nique F; Hebbe S; Peixoto C; Annoot D; Lefrançois JM; Duval E; Michoux L; Triballeau N; Lemoullec JM; Mollat P; Thauvin M; Prangé T; Minet D; Clément-Lacroix P; Robin-Jagerschmidt C; Fleury D; Guédin D; Deprez P
    J Med Chem; 2012 Oct; 55(19):8225-35. PubMed ID: 22897611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective androgen receptor modulators for frailty and osteoporosis.
    Kilbourne EJ; Moore WJ; Freedman LP; Nagpal S
    Curr Opin Investig Drugs; 2007 Oct; 8(10):821-9. PubMed ID: 17907058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators.
    Schlienger N; Lund BW; Pawlas J; Badalassi F; Bertozzi F; Lewinsky R; Fejzic A; Thygesen MB; Tabatabaei A; Bradley SR; Gardell LR; Piu F; Olsson R
    J Med Chem; 2009 Nov; 52(22):7186-91. PubMed ID: 19856921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.
    Miner JN; Chang W; Chapman MS; Finn PD; Hong MH; López FJ; Marschke KB; Rosen J; Schrader W; Turner R; van Oeveren A; Viveros H; Zhi L; Negro-Vilar A
    Endocrinology; 2007 Jan; 148(1):363-73. PubMed ID: 17023534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist.
    Kinoyama I; Taniguchi N; Toyoshima A; Nozawa E; Kamikubo T; Imamura M; Matsuhisa A; Samizu K; Kawanimani E; Niimi T; Hamada N; Koutoku H; Furutani T; Kudoh M; Okada M; Ohta M; Tsukamoto S
    J Med Chem; 2006 Jan; 49(2):716-26. PubMed ID: 16420057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituted benzothiophene or benzofuran derivatives as a novel class of bone morphogenetic protein-2 up-regulators: synthesis, structure-activity relationships, and preventive bone loss efficacies in senescence accelerated mice (SAMP6) and ovariectomized rats.
    Guo HF; Shao HY; Yang ZY; Xue ST; Li X; Liu ZY; He XB; Jiang JD; Zhang YQ; Si SY; Li ZR
    J Med Chem; 2010 Feb; 53(4):1819-29. PubMed ID: 20088515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective androgen receptor modulators: in pursuit of tissue-selective androgens.
    Omwancha J; Brown TR
    Curr Opin Investig Drugs; 2006 Oct; 7(10):873-81. PubMed ID: 17086931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives.
    Asano M; Hitaka T; Imada T; Yamada M; Morimoto M; Shinohara H; Hara T; Yamaoka M; Santou T; Nakayama M; Imai Y; Habuka N; Yano J; Wilson K; Fujita H; Hasuoka A
    Bioorg Med Chem Lett; 2017 May; 27(9):1897-1901. PubMed ID: 28363748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulators.
    Manfredi MC; Bi Y; Nirschl AA; Sutton JC; Seethala R; Golla R; Beehler BC; Sleph PG; Grover GJ; Ostrowski J; Hamann LG
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4487-90. PubMed ID: 17574413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulators.
    Piatnitski Chekler EL; Unwalla R; Khan TA; Tangirala RS; Johnson M; St Andre M; Anderson JT; Kenney T; Chiparri S; McNally C; Kilbourne E; Thompson C; Nagpal S; Weber G; Schelling S; Owens J; Morris CA; Powell D; Verhoest PR; Gilbert AM
    J Med Chem; 2014 Mar; 57(6):2462-71. PubMed ID: 24527807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel, non-steroidal, selective androgen receptor modulators (SARMs) with anabolic activity in bone and muscle and improved safety profile.
    Rosen J; Negro-Vilar A
    J Musculoskelet Neuronal Interact; 2002 Mar; 2(3):222-4. PubMed ID: 15758439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.